Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Preclinical News

Oct. 10 Preclinical Quick Takes: Merck- Prokaryotics Inc.-Princeton ID new antibiotic class; plus NIH, Owkin, Genentech and ICR

October 11, 2019 12:04 AM UTC
Updated on Oct 11, 2019 at 12:06 AM UTC

Merck, Prokaryotics, Princeton ID new class of antibiotic
Merck & Co. Inc. (NYSE:MRK), Prokaryotics Inc. and Princeton University researchers reported in a Proceedings of the National Academy of Sciences paper the identification of MRL-494, a small molecule representing a new antibiotics class that acts against Gram-negative and Gram-positive bacteria, but through different mechanisms. It blocks Gram-negative growth by impairing outer membrane protein biogenesis via inhibition of the β-barrel assembly complex protein BamA, which is required for assembly and integration of proteins into the outer membrane. It kills Gram-positive bacteria by permeabilizing the cell membrane.

NIH outlines program for molecular, cellular atlas of human body...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article